Safety and Efficacy of Evolocumab in Ischemic Stroke

• Status: Not yet recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this clinical trial is to evaluate the effect of evolocumab in combination with statin therapy (atorvastatin) in acute ischemic stroke (AIS).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second Affiliated Hospital of Guangxi Medical University
• Treatments: Evolocumab

Criteria

Inclusion Criteria:

1. Patient age between 18-80 years

2. Time of onset: within 1 week

3. NIHSS score ≤12

4. Acute ischemic stroke confirmed by head CT or MRI

5. Premorbid mRS ≤1

6. Signed informed consent

Exclusion Criteria:

1. Intracranial hemorrhage found by head CT

2. Severe hepatic or renal dysfunction

3. Pregnant females

4. Abnormal elevation of creatine phosphokinase

5. Blood sugar is out of control

6. Receiving statins within 1 month before onset

7. Not willing and able to comply with scheduled visits, lifestyle guidelines, treatment plan, laboratory tests, and other study procedures

8. Unsuitable for this clinical studies assessed by researcher